BioPharma Dive

With new approvals, Regeneron’s higher-dose Eylea gets more competitive

Analysts say the two new indications should help Eylea HD as Regeneron battles for market share with Roche’s Vabysmo.

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

Podcast Host, 47, Refuses to 'Hide' Her Plastic Surgery from Her Young Daughters for This One Reason (Exclusive)

Emese Gormley, who cohosts 'Lipstick on the Rim' with Molly Sims, turned to Dr. Robert Schwarcz for her procedure. Here, they ...